Post Market Clinical Follow-up Study for the Pamira ICD Lead Family
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 221 participants.
Also called NCT05621187
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose other
- Phase
- Not applicable
- Enrolled
- 221 participants
- Sponsor
- Registry
-
NCT05621187
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Australia, Austria, Belgium, Germany, Hungary, Israel, Latvia, Slovakia
- Registry status
- Completed
Technical summary
Registry record NCT05621187. Allocation not applicable; no masking; primary purpose other. Start 2022-11-30 (actual); primary completion 2025-01-20 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Post Market Clinical Follow-up Study for the Pamira ICD Lead Family
- Condition
- Heart Failure
- Condition
- Tachyarrhythmia
- Intervention (Device)
- Pamira ICD lead family
- Lead sponsor
- Biotronik SE & Co. KG
Record details
- Record id
cardio:ct-nct05621187- Content hash
76d5d842d026e19bd1c06fec3c23d77cb173e8c5c54ed343ddb00c0e038c784c